IGC Pharma Inc (IGC)
0.3768
-0.01
(-2.21%)
USD |
NYAM |
Nov 04, 16:00
0.398
+0.02
(+5.63%)
Pre-Market: 08:46
IGC Pharma Total Liabilities (Quarterly): 2.714M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 2.714M |
| March 31, 2024 | 2.581M |
| December 31, 2023 | 2.206M |
| September 30, 2023 | 2.408M |
| June 30, 2023 | 2.471M |
| March 31, 2023 | 2.267M |
| December 31, 2022 | 1.753M |
| September 30, 2022 | 1.814M |
| June 30, 2022 | 2.126M |
| March 31, 2022 | 2.942M |
| December 31, 2021 | 1.813M |
| September 30, 2021 | 2.58M |
| June 30, 2021 | 2.707M |
| March 31, 2021 | 3.064M |
| December 31, 2020 | 2.691M |
| September 30, 2020 | 2.748M |
| June 30, 2020 | 3.436M |
| March 31, 2020 | 2.447M |
| December 31, 2019 | 1.316M |
| September 30, 2019 | 1.645M |
| June 30, 2019 | 1.085M |
| March 31, 2019 | 0.893M |
| December 31, 2018 | 0.598M |
| September 30, 2018 | 2.743M |
| June 30, 2018 | 3.939M |
| Date | Value |
|---|---|
| March 31, 2018 | 2.788M |
| December 31, 2017 | 3.861M |
| September 30, 2017 | 3.771M |
| June 30, 2017 | 3.342M |
| March 31, 2017 | 3.934M |
| December 31, 2016 | 3.63M |
| September 30, 2016 | 4.035M |
| June 30, 2016 | 4.904M |
| March 31, 2016 | 4.911M |
| December 31, 2015 | 4.744M |
| September 30, 2015 | 4.731M |
| June 30, 2015 | 6.058M |
| March 31, 2015 | 5.582M |
| December 31, 2014 | 4.963M |
| September 30, 2014 | 5.264M |
| June 30, 2014 | 4.788M |
| March 31, 2014 | 3.589M |
| December 31, 2013 | 3.907M |
| September 30, 2013 | 4.077M |
| June 30, 2013 | 4.112M |
| March 31, 2013 | 4.278M |
| December 31, 2012 | 5.779M |
| September 30, 2012 | 9.042M |
| June 30, 2012 | 9.441M |
| March 31, 2012 | 9.444M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.316M
Minimum
Dec 2019
3.436M
Maximum
Jun 2020
2.426M
Average
2.471M
Median
Jun 2023
Total Liabilities (Quarterly) Benchmarks
| CEL-SCI Corp | 15.60M |
| AIM ImmunoTech Inc | 9.613M |
| NovaBay Pharmaceuticals Inc | 4.542M |
| Protalix BioTherapeutics Inc | 62.96M |
| Palatin Technologies Inc | 10.85M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.59M |
| Shareholders Equity (Quarterly) | 7.88M |
| Debt to Equity Ratio | 0.0173 |
| Current Ratio | 1.771 |
| Net Debt Paydown Yield | 0.00% |